Aebp2 as an Epigenetic Regulator for Neural Crest Cells

Aebp2 is a potential targeting protein for the mammalian Polycomb Repression Complex 2 (PRC2). We generated a mutant mouse line disrupting the transcription of Aebp2 to investigate its in vivo roles. Aebp2-mutant homozygotes were embryonic lethal while heterozygotes survived to adulthood with fertility. In developing mouse embryos, Aebp2 is expressed mainly within cells of neural crest origin. In addition, many heterozygotes display a set of phenotypes, enlarged colon and hypopigmentation, similar to those observed in human patients with Hirschsprung's disease and Waardenburg syndrome. These phenotypes are usually caused by the absence of the neural crest-derived ganglia in hindguts and melanocytes. ChIP analyses demonstrated that the majority of the genes involved in the migration and development process of neural crest cells are downstream target genes of AEBP2 and PRC2. Furthermore, expression analyses confirmed that some of these genes are indeed affected in the Aebp2 heterozygotes. Taken together, these results suggest that Aebp2 may regulate the migration and development of the neural crest cells through the PRC2-mediated epigenetic mechanism.

[1]  D. Reinberg,et al.  The Polycomb complex PRC2 and its mark in life , 2011, Nature.

[2]  M. Goossens,et al.  Review and update of mutations causing Waardenburg syndrome , 2010, Human mutation.

[3]  Juri Rappsilber,et al.  JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells , 2010, Nature.

[4]  Gang Li,et al.  Jarid2 and PRC2, partners in regulating gene expression. , 2010, Genes & development.

[5]  S. Orkin,et al.  Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells , 2009, Cell.

[6]  Arend Sidow,et al.  Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells , 2009, Cell.

[7]  Giacomo Cavalli,et al.  Recruitment of Polycomb group complexes and their role in the dynamic regulation of cell fate choice , 2009, Development.

[8]  M. Garcia-Barceló,et al.  Genetic basis of Hirschsprung’s disease , 2009, Pediatric Surgery International.

[9]  T. Sauka-Spengler,et al.  Evolution of the neural crest viewed from a gene regulatory perspective , 2008, Genesis.

[10]  Jennifer A. Erwin,et al.  Polycomb Proteins Targeted by a Short Repeat RNA to the Mouse X Chromosome , 2008, Science.

[11]  N. D. Clarke,et al.  Integration of External Signaling Pathways with the Core Transcriptional Network in Embryonic Stem Cells , 2008, Cell.

[12]  Marianne Bronner-Fraser,et al.  A gene regulatory network orchestrates neural crest formation , 2008, Nature Reviews Molecular Cell Biology.

[13]  R. Young,et al.  Stem Cells, the Molecular Circuitry of Pluripotency and Nuclear Reprogramming , 2008, Cell.

[14]  R. Jirtle,et al.  Environmental epigenomics and disease susceptibility , 2007, Nature Reviews Genetics.

[15]  J. Zeitlinger,et al.  Polycomb complexes repress developmental regulators in murine embryonic stem cells , 2006, Nature.

[16]  Megan F. Cole,et al.  Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells , 2006, Cell.

[17]  Kristian Helin,et al.  Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity , 2004, The EMBO journal.

[18]  Yi Zhang,et al.  SUZ12 is required for both the histone methyltransferase activity and the silencing function of the EED-EZH2 complex. , 2004, Molecular cell.

[19]  W. Pavan,et al.  Spotlight on spotted mice: a review of white spotting mouse mutants and associated human pigmentation disorders. , 2004, Pigment cell research.

[20]  Yasuhito Kobayashi,et al.  Mouse models for four types of Waardenburg syndrome. , 2003, Pigment cell research.

[21]  Anne Bergmann,et al.  Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3. , 2003, Human molecular genetics.

[22]  Minerva M. Carrasquillo,et al.  Genome-wide association study and mouse model identify interaction between RET and EDNRB pathways in Hirschsprung disease , 2002, Nature Genetics.

[23]  A Chakravarti,et al.  Hirschsprung disease, associated syndromes and genetics: a review , 2001, Journal of Medical Genetics.

[24]  D. Montell,et al.  Jing: a downstream target of slbo required for developmental control of border cell migration. , 2001, Development.

[25]  H. Ro,et al.  Cloning and Characterization of a Novel Zinc Finger Transcriptional Repressor , 1999, The Journal of Biological Chemistry.

[26]  J. Winer,et al.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. , 1999, Analytical biochemistry.

[27]  J. Milbrandt,et al.  GFRα1-Deficient Mice Have Deficits in the Enteric Nervous System and Kidneys , 1998, Neuron.

[28]  W. Colledge.  Manipulating the mouse embryo (2nd edn) , 1995 .

[29]  T. Magnuson,et al.  The eed mutation disrupts anterior mesoderm production in mice. , 1995, Development.

[30]  David J. Anderson,et al.  Isolation of a stem cell for neurons and glia from the mammalian neural crest , 1992, Cell.

[31]  Hana Kim,et al.  AEBP2 as a potential targeting protein for Polycomb Repression Complex PRC2 , 2009 .

[32]  A. McCallion,et al.  Genomic variation in multigenic traits: Hirschsprung disease. , 2003, Cold Spring Harbor symposia on quantitative biology.

[33]  M. Surani,et al.  The Polycomb-Group Gene Ezh2 Is Required for Early Mouse Development , 2001 .

[34]  J. Milbrandt,et al.  GFR alpha1-deficient mice have deficits in the enteric nervous system and kidneys. , 1998, Neuron.